Shareable Research Card

EVOME MEDICAL TECHNOLOGIES INC. Amortization of Intangible Assets

This metric view shows EVOME MEDICAL TECHNOLOGIES INC. amortization of intangible assets history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: Q4 2023
Latest reported value
CA$388,630

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 31 Dec 2023
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: Q4 2023.
  • Latest reported value on this page: CA$388,630.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Amortization of Intangible Assets

New fact period available

Latest reported amortization of intangible assets: CA$388,630. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

31 Dec 2023

Page type

Metric history

Latest period

Q4 2023

SEC-backed company facts were refreshed from filings filed on 16 Apr 2024.

Benchmark Context

How Amortization of Intangible Assets compares with peers

EVOME MEDICAL TECHNOLOGIES INC. sits in the bottom quarter of the current amortization of intangible assets sample.

Compared with

Compared with 11 companies reporting amortization of intangible assets in CAD. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0x the current sample midpoint. Amortization of Intangible Assets is up about 29% versus the comparable prior period.

  • Visible rows currently span reported period ends from 30 Jun 2020 to 31 Mar 2026.
  • Nearby companies in this sample: SRX Global Inc. and SusGlobal Energy Corp..
  • Current sample position: rank #10 of 11 comparable companies.
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Financial Metric Page

EVOME MEDICAL TECHNOLOGIES INC.: Amortization of Intangible Assets

Latest period: Q4 2023. Period end: 31 Dec 2023. Units: CAD. Frequency: quarterly and annual.

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

What this metric tells you

  • Shows reported amortization of intangible assets over 28 Feb 2021 - 31 Dec 2023.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 15 SEC fact rows for this metric and issuer.

How to read this chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.
  • Use the TTM line to smooth quarter-to-quarter noise.

Compare This Metric Across Companies

Compare latest available Amortization of Intangible Assets levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

EVOME MEDICAL TECHNOLOGIES INC. appears at rank #10 in the latest comparison sample.

Rank Company Latest value Report period Next step
1 NXT Energy Solutions Inc. (nsfdf) CA$68,902,000,000 Year - 31 Dec 2024 Open NXT Energy Solutions Inc. Amortization of Intangible Assets
2 ENBRIDGE INC (enb) CA$534,000,000 Year - 31 Dec 2025 Open ENBRIDGE INC Amortization of Intangible Assets
3 Fortis Inc. (fts) CA$160,000,000 Year - 31 Dec 2025 Open Fortis Inc. Amortization of Intangible Assets
4 Hydro One Ltd (hrnnf) CA$89,000,000 Year - 31 Dec 2025 Open Hydro One Ltd Amortization of Intangible Assets
5 HYDRO ONE INC CA$88,000,000 Year - 31 Dec 2025 Open HYDRO ONE INC Amortization of Intangible Assets
6 CANADIAN PACIFIC KANSAS CITY LTD/CN (cp) CA$87,000,000 Year - 31 Dec 2025 Open CANADIAN PACIFIC KANSAS CITY LTD/CN Amortization of Intangible Assets

Metric Details

Metric identity Names, identifiers, and filing context for this profile. 1 identity field
Taxonomy
us-gaap
Metric coverage 3 source fields
Units tracked
CAD
History range
28 Feb 2021 - 31 Dec 2023
Freshness: From parsed SEC XBRL facts on this page
Facts on this page
15
Source: SEC company facts API
How to read it 1 detail
Metric definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such...
Open details
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Source evidence Original filing metadata and source links for verification. 1 source field
SEC metric endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Amortization of Intangible Assets, Trailing 12 Months (CAD)
Amortization of Intangible Assets, Quarterly (CAD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (CAD)

EVOME MEDICAL TECHNOLOGIES INC. Quarterly Amortization of Intangible Assets (CAD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2023 CA$1,482,344 CA$388,630 +CA$86,640 +29% 01 Oct 2023 31 Dec 2023 10-K 16 Apr 2024 2023 Q4
Q3 2023 CA$1,395,704 CA$392,615 +CA$137,909 +54% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 CA$1,257,795 CA$350,553 +CA$101,524 +41% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 CA$1,156,271 CA$350,546 +CA$135,565 +63% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 CA$1,020,706 CA$301,990 +CA$136,438 +82% 01 Sep 2022 30 Nov 2022 10-Q 17 Jan 2023 2022 Q3
Q3 2022 CA$884,268 CA$254,706 +CA$184,097 +261% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 CA$700,171 CA$249,029 +CA$240,850 +2945% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 CA$459,321 CA$214,981 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 CA$165,552 +CA$165,552 01 Sep 2021 30 Nov 2021 10-Q 17 Jan 2023 2022 Q3
Q3 2021 CA$70,609 +CA$70,609 01 Jun 2021 31 Aug 2021 10-Q 17 Oct 2022 2022 Q2
Q2 2021 CA$8,179 22 May 2021 31 May 2021 10-Q/A 02 Aug 2021 2022 Q1
Q2 2021 CA$8,179 01 Mar 2021 31 May 2021 10-Q 15 Jul 2022 2023 Q1

EVOME MEDICAL TECHNOLOGIES INC. Annual Amortization of Intangible Assets (CAD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 CA$1,482,344 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024 2023 FY
2021 CA$448,348 +CA$448,348 01 Mar 2021 28 Feb 2022 10-KT 03 Apr 2023 2022 FY
2020 CA$0 01 Mar 2020 28 Feb 2021 10-K 31 May 2022 2022 FY
* marks a reported value that did not pass the local value check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .